<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc (NASDAQ: MRNA) defended using its COVID-19 vaccine, saying the protection it offers outweighs the risk of myocarditis seen in a small number of young men who received the shot, reports CNBC. The FDA last week said it requires more time to decide whether to authorize Moderna’s vaccine for use in children ages 12 to 17.
...read full article on Benzinga
